Editorial
Copyright ©The Author(s) 2015.
World J Hepatol. Apr 28, 2015; 7(6): 825-830
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.825
Table 2 Rates of hepatitis B virus reactivation during rituximab-containing chemotherapy in hepatitis B surface antigen-negative, antibody to hepatitis B core antigen positive individuals as described by various studies
Study regionStudy natureNo. of patientsHBV reactivation rateDefinition of HBV reactivation
Hong Kong[17]Retrospective2323.8%HBsAg seroreversion
Japan[27]Retrospective568.9%HBsAg seroreversion
Asia-Pacific[28]Retrospective1789.6%HBsAg seroreversion
Taiwan[29]Prospective15011.3%-18.9%Multiple virologic endpoints
Hong Kong[16]Prospective6341.5%Detectable HBV DNA